Risk Factors for Diabetic Peripheral Neuropathy and Cardiovascular Autonomic Neuropathy in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study demonstrated that intensive glucose control reduced the risk of developing diabetic peripheral neuropathy (DPN) and cardiovascular autonomic neuropathy (CAN). We evaluated multiple risk factors and phenotypes associated with DPN and CAN in this large, well-characterized cohort of participants with type 1 diabetes, followed for >23 years. DPN was defined by symptoms, signs, and nerve conduction study abnormalities in ≥2 nerves; CAN was assessed using standardized cardiovascular reflex tests. Generalized estimating equation models assessed the association of DPN and CAN with individual risk factors measured repeatedly. During DCCT/EDIC, 33% of participants developed DPN and 44% CAN. Higher mean HbA1c was the most significant risk factor for DPN, followed by older age, longer duration, greater height, macroalbuminuria, higher mean pulse rate, β-blocker use, and sustained albuminuria. The most significant risk factor for CAN was older age, followed by higher mean HbA1c, sustained albuminuria, longer duration of type 1 diabetes, higher mean pulse rate, higher mean systolic blood pressure, β-blocker use, estimated glomerular filtration rate <60 mL/min/1.73 m2, higher most recent pulse rate, and cigarette smoking. These findings identify risk factors and phenotypes of participants with diabetic neuropathy that can be used in the design of new interventional trials and for personalized approaches to neuropathy prevention.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, persons who fail to return for continued anti-VEGF treatments are at risk of losing vision.537,538”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [538]
In the citing paper
“The prevalence of and risk factors for standard resting ECG-derived CAN were similar to previously reported estimates from CARTs.”
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423 · cited 1×
“LDL cholesterol was calculated using the Friedewald equation (17).”
Method(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Self-citationInternational Diabetes Federation 2017
Carracher, A. M., Marathe, P. H., & Close, K. L. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12644 · Cited by 13,418
Antihyperlipidemic and Biochemical Activities of Mcy Protein in Streptozotocin Induced Diabetic Rats
Marella, S., Maddirela, D. R., Badri, K. R., Jyothi Kumar, M. V., & Chippada, A. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373954 · Cited by 5,938
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.04.025 · Cited by 3,418 · cited 1×
“Although evidence for the benefit of b-blockers in modulating the impaired cardiac autonomic regulation during high sympathetic stress advocates for their use in patients with heart failure and/or post myocardial infarction (38), these agents are not currently recommended for the treatment of CAN (1).”
Diabetic neuropathy: A position statement by the American Diabetes Association
Pop-Busui, R., Boulton, A. J. M., Feldman, E. L., Bril, V., Freeman, R., Malik, R. A., Sosenko, J. M., & Ziegler, D. (2017) · Diabetes Care · doi:10.2337/dc16-2042 · Cited by 2,602 · cited 2×
“Although evidence for the benefit of b-blockers in modulating the impaired cardiac autonomic regulation during high sympathetic stress advocates for their use in patients with heart failure and/or post myocardial infarction (38), these agents are not currently recommended for the treatment of CAN (1).”
BackgroundSelf-citationPrevalence of Type 1 and Type 2 Diabetes Among Children and Adolescents From 2001 to 2009
Dabelea, D., Mayer-Davis, E. J., Saydah, S., Imperatore, G., Linder, B., Divers, J., Bell, R., Badaru, A., Talton, J. W., Crume, T., et al. (2014) · JAMA · doi:10.1001/jama.2014.3201 · Cited by 1,412
Vascular risk factors and diabetic neuropathy
Tesfaye, S., Chaturvedi, N., Eaton, S. E. M., Ward, J. D., Manes, C., Ionescu-Tirgoviste, C., Witte, D. R., & Fuller, J. H. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa032782 · Cited by 1,323
New Horizons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and Pain
Feldman, E. L., Nave, K.-A., Jensen, T. S., & Bennett, D. L. H. (2017) · Neuron · doi:10.1016/j.neuron.2017.02.005 · Cited by 915 · cited 1×
“The mechanisms linking hypertension to DPN are unclear but may involve a complex set of pathways interlinking nerve function and energy production with a dysfunctional neural vascular supply (29).”
BackgroundSelf-citation2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2017) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2017.04.014 · Cited by 770
Research works printed but not linked: 1
- International Diabetes Federation. IDF Diabetes Atlas, 9th edition [Internet], 2019. Available from https://diabetesatlas.org
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Self-citationPathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy
Sloan, G., Selvarajah, D., & Tesfaye, S. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00496-z · Cited by 534
The Role of Inflammation in Diabetic Retinopathy
Forrester, J. V., Kuffova, L., & Delibegovic, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.583687 · Cited by 432
“Although etiologically different, both conditions are characterized by hyperglycemia and dyslipidemia which are considered major risk factors for development of the shared macrovascular and microvascular complications as well as neurological dysfunction (15); moreover, the two conditions can coexist (4).”
BackgroundElafros, M. A., Andersen, H., Bennett, D. L., Savelieff, M. G., Viswanathan, V., Callaghan, B. C., & Feldman, E. L. (2022) · The Lancet Neurology · doi:10.1016/s1474-4422(22)00188-0 · Cited by 387
Self-citationDiabetic neuropathy: cutting-edge research and future directions
Yang, Y., Zhao, B., Wang, Y., Lan, H., Liu, X., Hu, Y., & Cao, P. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02175-1 · Cited by 234
“33,34 The number of young individuals diagnosed with T2DM has been increasing.”
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options
Galiero, R., Caturano, A., Vetrano, E., Beccia, D., Brin, C., Alfano, M., Di Salvo, J., Epifani, R., Piacevole, A., Tagliaferri, G., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043554 · Cited by 225
“As demonstrated by some trials, diabetic peripheral neuropathy (DPN) often is not present at the moment of diagnosis, while it could appear after at least 10 years of disease duration, and could affect up to 34% of subjects after ~25 years [5,6].”
BackgroundTobias, D. K., Merino, J., Ahmad, A., Aiken, C., Benham, J. L., Bodhini, D., Clark, A. L., Colclough, K., Corcoy, R., Cromer, S. J., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02502-5 · Cited by 217
Diabetic neuropathy and neuropathic pain: a (con)fusion of pathogenic mechanisms?
Calcutt, N. A. (2020) · Pain · doi:10.1097/j.pain.0000000000001922 · Cited by 159
Li, Z., Zhao, Y., Liu, H., Ren, M., Wang, Z., Wang, X., Liu, H., Feng, Y., Lin, Q., Wang, C., et al. (2021) · Materials & Design · doi:10.1016/j.matdes.2021.110104 · Cited by 157
Bjornstad, P., Dart, A. B., Donaghue, K. C., Dost, A., Feldman, E. L., Tan, G. S. W., Wadwa, R. P., Zabeen, B., & Marcovecchio, M. L. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13444 · Cited by 195
Self-citationBai, H., Kyu-Cheol, N., Wang, Z., Cui, Y., Liu, H., Liu, H., Feng, Y., Zhao, Y., Lin, Q., & Li, Z. (2020) · Journal of Tissue Engineering · doi:10.1177/2041731420947242 · Cited by 146
Ferdousi, M., Kalteniece, A., Azmi, S., Petropoulos, I. N., Ponirakis, G., Alam, U., Asghar, O., Marshall, A. G., Fullwood, C., Jeziorska, M., et al. (2020) · Diabetes Care · doi:10.2337/dc20-1482 · Cited by 110
“The Diabetes Control and Complications Trial (DCCT) also demonstrated that elevated triglycerides were a risk factor for the development of DPN in patients with type 1 diabetes (34).”
BackgroundWu, B., Niu, Z., & Hu, F. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0100 · Cited by 93
“The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study identified age as the most significant risk factor for DPN other than HbA1c levels [20].”
BackgroundCardiac Autonomic Neuropathy in Type 1 and 2 Diabetes: Epidemiology, Pathophysiology, and Management
Williams, S., Raheim, S. A., Khan, M. I., Rubab, U., Kanagala, P., Zhao, S. S., Worthington, A., Brown, E. E., & Alam, U. (2022) · Clinical Therapeutics · doi:10.1016/j.clinthera.2022.09.002 · Cited by 112
Glycated Hemoglobin (HbA1c) as a Biomarker for Diabetic Foot Peripheral Neuropathy
Casadei, G., Filippini, M., & Brognara, L. (2021) · Diseases · doi:10.3390/diseases9010016 · Cited by 112
“Braffett (2020) [76] Cohort Study 1441 27 52% M 48% F Type 1 8.”
Spectrum of Diabetic Neuropathy: New Insights in Diagnosis and Treatment
Dillon, B. R., Ang, L. P., & Pop‐Busui, R. (2024) · Annual Review of Medicine · doi:10.1146/annurev-med-043021-033114 · Cited by 105
Self-citationPrevention and Management Strategies for Diabetic Neuropathy
Smith, S., Normahani, P., Lane, T. R. A., Hohenschurz‐Schmidt, D., Oliver, N. S., & Davies, A. H. (2022) · Life · doi:10.3390/life12081185 · Cited by 99
“A recent review of DCCT/EDIC data validated these risk factors, as well as height, macroalbuminuria, pulse rate, beta-blocker use and sustained albuminuria [32].”
BackgroundMethodThe Treatment of Painful Diabetic Neuropathy
SLOAN, G. P., Alam, U., Selvarajah, D., & Tesfaye, S. H. (2021) · Current Diabetes Reviews · doi:10.2174/1573399817666210707112413 · Cited by 71
Tang, Y., Shah, H., Bueno Junior, C. R., Sun, X., Mitri, J., Sambataro, M., Sambado, L., Gerstein, H. C., Fonseca, V., Doria, A., et al. (2021) · Diabetes Care · doi:10.2337/dc20-1842 · Cited by 60
“93) among patients with type 1 diabetes (19) that continues over time (20), but are at variance with thoseof theVeteransAffairsDiabetes Trial (VADT), in which intensive glycemic control did not show any beneficial effect on autonomic neuropathy among T2D subjects.”
BackgroundSelf-citationLytvyak, E., Straube, S., Modi, R., & Lee, K. K. C. (2022) · CMAJ Open · doi:10.9778/cmajo.20210205 · Cited by 86
Hsieh, R.-Y., Huang, I.-C., Chen, C., & Sung, J. (2023) · Nutrients · doi:10.3390/nu15163634 · Cited by 80
“Several risk factors influence the progression of diabetic neuropathy, including the duration of diabetes, poor glycemic control, and obesity [3,4].”
BackgroundSchwartz, A. V., Backlund, J. C., de Boer, I. H., Rubin, M. R., Barnie, A., Farrell, K., Trapani, V. R., Gregory, N. S., Wallia, A., Bebu, I., et al. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00103-6 · Cited by 59
Self-citationPop‐Busui, R., Backlund, J. C., Bebu, I., Braffett, B. H., Lorenzi, G., White, N. H., Lachin, J. M., Soliman, E. Z., & DCCT/EDIC Research Group (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13635 · Cited by 52
Self-citationThe conundrum of diabetic neuropathies—Past, present, and future
Ang, L. P., Mizokami‐Stout, K., Eid, S., Elafros, M. A., Callaghan, B. C., Feldman, E. L., & Pop‐Busui, R. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108334 · Cited by 66
Self-citationFranceschi, R., Mozzillo, E., Candia, F. D., Rosanio, F. M., Leonardi, L., Liguori, A., Micheli, F., Cauvin, V., Franzese, A., Piona, C. A., et al. (2022) · Acta Diabetologica · doi:10.1007/s00592-022-01850-x · Cited by 58
Kaur, M., Misra, S., Swarnkar, P., Patel, P., Kurmi, B. D., Gupta, G. D., & Singh, A. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115723 · Cited by 62
DNA methylation age calculators reveal association with diabetic neuropathy in type 1 diabetes
Roshandel, D., Chen, Z., Canty, A. J., Bull, S. B., Natarajan, R. D., & Paterson, A. D. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-00840-6 · Cited by 53
Bashir, B., Ho, J. H., Downie, P., Hamilton, P., Ferns, G. A., Datta, D. B. N., Cegla, J., Wierzbicki, A. S., Dawson, C., Jenkinson, F., et al. (2023) · Metabolites · doi:10.3390/metabo13050621 · Cited by 52
Balaratnasingam, C., An, D., Hein, M., Yu, P. K., & Yu, D. (2022) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2022.101134 · Cited by 51
Hamilton, E. J., Davis, W. A., Siru, R., Baba, M., Norman, P. E., & Davis, T. M. E. (2021) · Diabetes Care · doi:10.2337/dc20-1743 · Cited by 40
Pathogenesis of Distal Symmetrical Polyneuropathy in Diabetes
Smith, S., Normahani, P., Lane, T. R. A., Hohenschurz‐Schmidt, D., Oliver, N. S., & Davies, A. H. (2022) · Life · doi:10.3390/life12071074 · Cited by 48
“As a result, the industry has been hesitant to invest in such research, despite the fact that it is critical for further knowledge and given that current management strategies focus on prevention and pain management, which often fail to achieve long-term efficacy [29].”
BackgroundDiabetic Autonomic Neuropathy: A Clinical Update
Sharma, J. K., Rohatgi, A., & Sharma, D. (2020) · The Journal of the Royal College of Physicians of Edinburgh · doi:10.4997/jrcpe.2020.310 · Cited by 41
Nabrdalik, K., Kwiendacz, H., Moos, J., Moos, Ł., Kulpa, J., Brzoza, Z., Stompór, T. P., Gumprecht, J., & Lip, G. Y. H. (2023) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2023.101726 · Cited by 48
Psychosocial Care for People With Diabetic Neuropathy: Time for Action
Pouwer, F., Mizokami‐Stout, K., Reeves, N. D., Pop‐Busui, R., Tesfaye, S. H., Boulton, A. J. M., & Vileikytė, L. (2023) · Diabetes Care · doi:10.2337/dci23-0033 · Cited by 47
Self-citationAleidan, F. A. S., Ahmed, B. A., Alotaibi, F., Aleesa, D. H., Al-Hefdhi, N., Badri, M., & Gader, A. G. A. (2020) · International Journal of General Medicine · doi:10.2147/ijgm.s273807 · Cited by 56
Diabetic neuropathy in children and youth: New and emerging risk factors
Akıncı, G., Savelieff, M. G., Gallagher, G., Callaghan, B. C., & Feldman, E. L. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13153 · Cited by 33
Self-citationMultidisciplinary Progress in Obesity Research
Lu, X., Jin, Y., Li, D., Zhang, J., Han, J., & Li, Y. (2022) · Genes · doi:10.3390/genes13101772 · Cited by 37
“Among the various forms of diabetic neuropathy, distal symmetrical polyneuropathy and diabetic autonomic neuropathy, especially cardiovascular autonomic neuropathy (CAN), are currently the most studied [14].”
BackgroundInfluentialLv, Y., Yao, X., Li, X., Ouyang, Y., Fan, C., & Qian, Y. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.380872 · Cited by 35
Biochemical Markers of Bone Turnover in Older Adults With Type 1 Diabetes
Rubin, M. R., de Boer, I. H., Backlund, J. C., Arends, V. L., Gubitosi‐Klug, R., Wallia, A., Gregory, N. S., Barnie, A., Burghardt, A. J., Lachin, J. M., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac099 · Cited by 26
Self-citationChen, M., Qin, Q., Liu, F., Wang, Y., Wu, C., Yan, Y., & Xiang, H. (2022) · Environmental Research · doi:10.1016/j.envres.2022.113158 · Cited by 28
Serum uric acid and diabetic peripheral neuropathy: a double-edged sword
Zhuang, Y., Huang, H., Hu, X., Zhang, J., & Cai, Q. (2022) · Acta Neurologica Belgica · doi:10.1007/s13760-022-01978-1 · Cited by 32
Hendrickx, J. O., Martinet, W., Dam, D. V., & Meyer, G. R. Y. D. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.651215 · Cited by 30
Raghavan, S., Huang, J., Tcheandjieu, C., Huffman, J. E., LITKOWSKI, E. M., Liu, C., Ho, Y.-L. A., Hunter-Zinck, H., Zhao, H., Marouli, E., et al. (2022) · PLoS Genetics · doi:10.1371/journal.pgen.1010193 · Cited by 25
Lin, X., Chen, C., Liu, Y., Yu, P., Chen, Z., Huang, H., & Xu, L. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.709114 · Cited by 23
Yağın, F. H., Çolak, C., Algarni, A., Görmez, Y., Güldoğan, E., & Ardigò, L. P. (2024) · Diagnostics · doi:10.3390/diagnostics14131364 · Cited by 26
Yang, X., Li, X., Zhu, Y., Gao, Y., & Xu, L. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/4775645 · Cited by 26
“Despite decades of research, our understanding of the molecular mechanisms underlying is still in its infancy [2, 3].”
Maddaloni, E., Moretti, C., Toro, R. D., Sterpetti, S., Ievolella, M. V., Arnesano, G., Strollo, R., Briganti, S., D’Onofrio, L., Pozzilli, P., et al. (2020) · Diabetic Medicine · doi:10.1111/dme.14455 · Cited by 22
Cuyubamba, O., Braga, C., Swift, D. D., Stickney, J. T., & Viel, C. (2025) · Cells · doi:10.3390/cells14070477 · Cited by 20
“While the risk factor with the strongest association for developing DPN is poor glycemic control [20–22], other independent risk factors like obesity, an increased waist-to-hip ratio, hypertension, dyslipidemia, hypertriglyceridemia and smoking are well-described [20,21,23–26].”
Braffett, B. H., Bebu, I., Lorenzi, G. M., Martin, C. L., Perkins, B. A., Gubitosi‐Klug, R., & Nathan, D. M. (2025) · Diabetes Care · doi:10.2337/dc24-2885 · Cited by 28
Self-citationA systematic review on the efficacy of vitamin B supplementation on diabetic peripheral neuropathy
Farah, S., & Yammine, K. (2021) · Nutrition Reviews · doi:10.1093/nutrit/nuab116 · Cited by 20
Diabetic Foot Ulcers and Cardiac Autonomic Neuropathy
Basra, R., Παπάνας, Ν., Farrow, F., Karalliedde, J. J., & Vas, P. R. J. (2021) · Clinical Therapeutics · doi:10.1016/j.clinthera.2021.12.002 · Cited by 22
Urbano, F., Farella, I., Brunetti, G., & Faienza, M. F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241511980 · Cited by 25
Neuropathic Pain With and Without Diabetic Peripheral Neuropathy in Type 1 Diabetes
Braffett, B. H., ghormli, L. K. E., Albers, J. W., Feldman, E. L., Herman, W. H., Gubitosi‐Klug, R., Martin, C. L., Orchard, T. J., White, N. H., Lachin, J. M., et al. (2024) · Diabetes Care · doi:10.2337/dc23-1749 · Cited by 23
Self-citationMizrak, H. I., Kufaishi, H., Hecquet, S. K., Hansen, T. W., Pop‐Busui, R., Rossing, P. R., Brock, B., & Hansen, C. S. (2024) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2024.108761 · Cited by 18
Self-citationHbA1c Variability as an Independent Risk Factor for Microvascular Complications in Type 1 Diabetes
Mao, Y., & Zhong, W. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221100833 · Cited by 20
“13 The presence of autonomic neuropathy was evaluated using cardiovascular autonomic reflex tests that assessed the R-R response to paced breathing (R-R variation), the Valsalva maneuver, and postural changes in blood pressure in EDIC year 13 or 14.”
BackgroundMethodKarger, A. B., Nasrallah, I. M., Braffett, B. H., Luchsinger, J. A., Ryan, C. M., Bebu, I., Arends, V. L., Habes, M., Gubitosi‐Klug, R., Chaytor, N. S., et al. (2024) · Diabetes Care · doi:10.2337/dc24-0229 · Cited by 21
Self-citationUric acid in diabetic microvascular complications: Mechanisms and therapy
Li, X., Huang, B., Liu, Y., Wang, M., & Cui, J. (2024) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2024.108929 · Cited by 20
The Epidemiology of Diabetic Neuropathy
Hansen, C. S., Määttä, L. L., Andersen, S. T., & Charles, M. H. (2023) · Contemporary Diabetes · doi:10.1007/978-3-031-15613-7_2 · Cited by 17
Zhang, Y., Chen, B., Chen, Z., & Wan, Q. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1302615 · Cited by 19
Lin, J., Xiang, X., Qin, Y., Gui, J., & Wan, Q. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1037969 · Cited by 18
He, Q., Zeng, Z., Zhao, M., Ruan, B., & Chen, P. (2023) · Scientific Reports · doi:10.1038/s41598-023-40752-y · Cited by 20
“(3) Infectious diseases, abnormal blood pressure and patients with tumors, severe liver and kidney diseases.”
BackgroundGlucagon-like peptide-1 receptor agonists for the management of diabetic peripheral neuropathy
Liu, C., Wu, T., & Ren, N. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1268619 · Cited by 22
Study of the Involvement of the P2Y12 Receptor in Chronic Itching in Type 2 Diabetes Mellitus
Xu, X., Zhang, H., Li, L., Yang, R., Li, G., Liu, S., Schmalzing, G., Nie, H., & Liang, S. (2022) · Molecular Neurobiology · doi:10.1007/s12035-021-02676-4 · Cited by 16
Bashar, M. A., & Verma, M. (2020) · Iberoamerican Journal of Medicine · doi:10.53986/ibjm.2021.0005 · Cited by 17
Autonomic diabetic neuropathies: A brief overview
Pop‐Busui, R. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110762 · Cited by 29
Self-citationPancreatic and cardiometabolic complications of severe hypertriglyceridaemia
Bashir, B., Ferdousi, M., Durrington, P. N., & Soran, H. (2024) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000939 · Cited by 14
Symptomatic diabetic autonomic neuropathy in type 1 diabetes (T1D): Findings from the T1D exchange
Mizokami‐Stout, K., Bailey, R. J., Ang, L. P., Aleppo, G., Levy, C. J., Rickels, M. R., Shah, V. N., Polsky, S., Nelson, B., Carlson, A. L., et al. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108148 · Cited by 14
Self-citationHuang, Z., Gao, J., Zhang, H., You, S., Xiong, Z.-C., Wu, Y., Guo, D., Wang, J., Chen, Y., Zhang, S., et al. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15583 · Cited by 15
“8,9 Given the widespread prevalence and grave severity of these vascular complications, it is essential to identify effective strategies for preventing or delaying the onset of both macrovascular and microvascular complications in individuals living with diabetes.”
BackgroundPop‐Busui, R., Patel, A., Sang, C. N.-M., Banks, P. L., Pierce, P. F., Sun, F., Granowitz, C. B., & Gopinathan, S. (2024) · Diabetes Care · doi:10.2337/dc24-0188 · Cited by 15
Self-citationZhang, X., Zhang, X., Li, X., Zhao, X., Wei, G., Shi, J., Yang, Y., Su, F., Zhao, J., Zhu, K., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1416311 · Cited by 18
Neuropathy and the metabolic syndrome
Piccolo, N., Wiggers, A., Koubek, E. J., & Feldman, E. L. (2024) · eNeurologicalSci · doi:10.1016/j.ensci.2024.100542 · Cited by 15
Self-citationHeart rate‐corrected QT interval: A novel diagnostic biomarker for diabetic peripheral neuropathy
Jiang, A., Gu, H., Feng, Z., Ding, Y., Xu, X., Yin, G., Zhang, W., Shen, Z., & Li, Q. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13738 · Cited by 11
Keshavarzi, S., Braffett, B. H., Pop‐Busui, R., Orchard, T. J., Soliman, E. Z., Lorenzi, G. M., Barnie, A., Karger, A. B., Gubitosi‐Klug, R., Dagogo-Jack, S. E., et al. (2021) · Diabetes Care · doi:10.2337/dc20-2387 · Cited by 13
“The beneficial effect of former intensive therapy on the risk of incident CAN was mostly explained by the differences in DCCT/EDIC mean HbA1c.”
ResultSelf-citationAutonomic Dysfunction from Diagnosis to Treatment
Peltier, A. (2024) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2024.02.006 · Cited by 12
Brock, C., Andersen, H., Alibegovic, A. C., Andersen, S. R. D., Andreasen, L., Charles, M., Christensen, D. H., Drewes, A. M., Gall, M.-A., Gylfadottir, S. S., et al. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112010 · Cited by 12
Self-citationDeterminants of the heart rate variability in type 1 diabetes mellitus
Hajdu, M., Garmpis, K., Vértes, V., Vorobcsuk-Varga, N., Molnár, G. A., Hejjel, L., Wittmann, I., & Faludi, R. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1247054 · Cited by 16
Reddy, R. S., Alshahrani, M. S., Tedla, J. S., Asiri, F., Nambi, G. S., & Kakaraparthi, V. N. (2022) · Journal of Manipulative and Physiological Therapeutics · doi:10.1016/j.jmpt.2022.06.008 · Cited by 11
Chaytor, N. S., Trapani, V. R., Braffett, B. H., Fonseca, L. M., Lorenzi, G. M., Gubitosi‐Klug, R., HITT, S. M., Farrell, K., Jacobson, A. M., & Ryan, C. M. (2023) · The Clinical Neuropsychologist · doi:10.1080/13854046.2023.2266876 · Cited by 10
“Neurologic evaluations, nerve conduction studies, and cardiac autonomic testing were conducted periodically (Braffett et al., 2020).”
BackgroundSelf-citationAn Overview on Diabetic Neuropathy
Singh, U., Sharma, R., & Kumar, R. (2024) · Current Diabetes Reviews · doi:10.2174/0115733998295741240606104106 · Cited by 14
Nakazawa, S., Fukai, K., Furuya, Y., Kojimahara, N., Hoshi, K., Toyota, A., & Tatemichi, M. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109809 · Cited by 15
Jadhao, P. A., Swain, J., Das, S., Mangaraj, S., & Sravya, S. L. (2024) · Current Diabetes Reviews · doi:10.2174/0115733998282818240125110248 · Cited by 14
Xie, J., Du, R., Li, Q., & Li, L. (2023) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-023-01212-5 · Cited by 12
Roohi, T. F., Mehdi, S., Aarfi, S., Krishna, K. L., Pathak, S., Suhail, S. M., & Faizan, S. (2023) · Diabetology International · doi:10.1007/s13340-023-00680-8 · Cited by 12
“Diabetic Peripheral Neuropathy (DPN) is one of the most prevalent chronic complications in adults with long-lasting DM in both T1DM and T2DM patients, while also affecting individuals with prediabetes and young people with diabetes, with an estimated lifetime prevalence exceeding 50% [87–91].”
Progression from Prediabetes to Diabetes in a Diverse U.S. Population: A Machine Learning Model
Aoki, J., Khalid, O. M., Kaya, C., Nagymányoki, Z., Hussong, J. W., & Salama, M. E. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0052 · Cited by 12
Cefalu, W. T., & Rodgers, G. P. (2024) · Diabetes Care · doi:10.2337/dci24-0030 · Cited by 11
Nerve decompression for diabetic peripheral neuropathy with nerve entrapment: a narrative review
Liao, C., & Zhang, W. (2024) · Therapeutic Advances in Neurological Disorders · doi:10.1177/17562864241265287 · Cited by 10
Upper-Limb Complications in Diabetes: A Narrative Review
Braffett, B. H., Berg, T. J., Zimmerman, M., Olesen, K., Gregersen, S., Krogsgaard, M. R., Dahlin, L. B., & Nørgaard, K. (2025) · Diabetes Care · doi:10.2337/dci25-0012 · Cited by 13
Self-citationAdvances in the pathophysiology and treatment of diabetic peripheral neuropathy
Fridman, V., Elafros, M. A., Eid, S., Reynolds, E. L., McCray, B. A., & Callaghan, B. C. (2026) · BMJ · doi:10.1136/bmj-2024-081217 · Cited by 16
Xie, J., Yu, X., Chen, L., Cheng, Y., Li, K., Song, M., Chen, Y., Feng, F., Cai, Y., Tong, S., et al. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70040 · Cited by 11
Steigmann, L., Maekawa, S., Kauffmann, F., Reiss, J., Cornett, A. M., Sugai, J. V., Venegas, J., Fan, X., Xie, Y., Giannobile, W. V., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-15430-0 · Cited by 13
Self-citationFelício, J. S., de Moraes, L. V., Lemos, G., de Souza, Í. J. A., Vieira, G. C., Silva, L. D. S. D., de Queiroz, N. N. M., Souza, A. C., de Melo, F. T. C., Neto, J. F. A., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-56934-1 · Cited by 10
Lei, M., Zhou, Y., Ni, Y., Lin, Z., Lin, Q., Ling, P., Yang, D., Xu, W., Deng, H., & Yan, J. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70355 · Cited by 9
“29,30 Most critically from a safety perspective, we observed a marked 84% reduction in the risk of SH, with a number-needed-to-treat of 20.”
Bosoni, P., Calcaterra, V., Tibollo, V., Malovini, A. L., Zuccotti, G., Mameli, C., Sacchi, L., Bellazzi, R., & Larizza, C. (2021) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2020-0725 · Cited by 11
Takri, T., Mathew, R. R., Sivadasan, A., Raju, K., Karuppusami, R., & Mariappan, R. (2021) · Journal of Neurosurgical Anesthesiology · doi:10.1097/ana.0000000000000824 · Cited by 11
Huo, J., Xue, Y., Dong, X., Lv, J., Wu, L., Gao, H., Yang, X., Liu, H., & Gao, Q. (2022) · Nutritional Neuroscience · doi:10.1080/1028415x.2022.2090606 · Cited by 9
Nathan, D. M., & Lachin, J. M. (2024) · Diabetes Care · doi:10.2337/dci24-0063 · Cited by 8
Self-citationLi, K., Geng, W., Zhao, W., Huang, K., Lu, Q., Tao, B., Chen, S., Yan, C., Jiang, D., & Guo, A. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.154522 · Cited by 35
Tian, Z., Fan, Y., Sun, X., Wang, D., Guan, Y., Zhang, Y., Zhang, Z., Guo, J., Bu, H., Wu, Z., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e17339 · Cited by 9
Poulsen, M. B., Wegeberg, A., Røikjer, J., Nikontovic, A., Vestergaard, P., & Brock, C. (2024) · Acta Diabetologica · doi:10.1007/s00592-024-02390-2 · Cited by 10
“Previous prevalence estimates vary widely due to differences in study design and cohorts [ 3, 5] with studies reporting 33–44% in T1D [6, 7] and up to 73% in T2D [8].”
Obesity, Metabolic Health, and Diabetic Complications in People With Type 1 Diabetes
Mao, Y., Gau, J., & Jiang, N. (2024) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70017 · Cited by 7
Metadata
- Authors
- Braffett, B. H., Gubitosi-Klug, R. A., Albers, J. W., Feldman, E. L., Martin, C. L., White, N. H., Orchard, T. J., Lopes-Virella, M., Lachin, J. M., Pop-Busui, R., & the DCCT/EDIC Research Group
- Affiliations
- George Washington University (US)
- Rainbow Babies & Children’s Hospital, Case Western Reserve University, Cleveland, OH
- University of Michigan (US)
- Washington University in St. Louis (US)
- University of Pittsburgh (US)
- Medical University of South Carolina (US)
- University of Michigan Medical School, Ann Arbor, MI
- Corresponding author
- Braffett, Barbara H.
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2020-02-12
- Volume
- 69
- Issue
- 5
- Pages
- 1000-1010
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC7171957
- OpenAlex
- W3006227931
- Cited by
- 221
- References
- 40
- Citations by year
- 2026: 26 · 2025: 41 · 2024: 45 · 2023: 31 · 2022: 40 · 2021: 24 · 2020: 14
- FWCI
- 20.55
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Diabetes (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5u01dk094157-13, UL1TR002345)
- National Institute of Diabetes and Digestive and Kidney Diseases (U01DK094176, U01-DK094157, P30DK092926, P30DK020572, P30DK017047)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- diabetic peripheral neuropathy, cardiac autonomic neuropathy, type 1 diabetes, risk factors, tight glycemic control, HbA1c, albuminuria, macroalbuminuria, beta-blocker use, pulse rate, cigarette smoking, neuropathy prevention, DCCT/EDIC
- MeSH terms
- Adult, Autonomic Nervous System, Blood Glucose, Cardiovascular Diseases, Diabetes Mellitus, Type 1, Diabetic Neuropathies, Female, Glycated Hemoglobin, Humans, Longitudinal Studies, Male, Risk Factors, Cohort Studies, Multivariate Analysis, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.